ETS相关基因激活可保护微血管内皮细胞黏附连接与通透性
本文研究ERG转录因子在人肺微血管内皮细胞(HLMEC)中对微血管屏障与通透性的调控作用。将HLMEC单层培养于Transwell小体,分别转染ERG CRISPR/cas9敲低质粒、ERG CRISPR激活质粒、重组ERG蛋白或各自对照,并以重组VEGF作为通透性诱导剂。结果:CRISPR/cas9敲低ERG及VEGF处理均诱导单层高通透性、VE-cadherin与β-catenin连接处重分布及细胞骨架F-actin应力纤维形成;CRISPR激活ERG及重组ERG转染减轻VEGF诱导的单层高通透性,并保护黏附连接与细胞骨架。结论认为ERG是人肺微血管内皮细胞屏障完整性与通透性的强效调控因子,内源性或外源性增强ERG可提供对抗屏障功能障碍与高通透性的保护。
要点
- 在人肺微血管内皮细胞(HLMEC)单层中,CRISPR/cas9敲低ERG可诱导单层高通透性及VE-cadherin、β-catenin连接处重分布与F-actin应力纤维形成。
- VEGF处理同样诱导HLMEC单层高通透性、VE-cadherin与β-catenin连接处重分布及F-actin应力纤维形成。
- CRISPR激活ERG与重组ERG转染均可减轻VEGF诱导的单层高通透性,并保护黏附连接与细胞骨架。
- 作者结论:ERG是人肺微血管内皮细胞屏障完整性与通透性的强效调控因子,内源性或外源性增强ERG可提供对抗屏障功能障碍与高通透性的保护。
适用人群与场景
- 人肺微血管内皮细胞(HLMEC)单层,体外培养于Transwell小体;原文提及创伤-失血性休克与烧伤等多种疾病和临床情况可导致微血管功能障碍、微血管通透性过高、组织水肿,最终多器官功能障碍和死亡。
处置流程与药物剂量
- 体外实验干预:HLMEC单层分别转染ERG CRISPR/cas9敲低质粒、ERG CRISPR激活质粒、重组ERG蛋白或各自对照;以重组VEGF作为通透性诱导剂。
- 采用单层通透性实验及免疫荧光检测黏附连接蛋白VE-cadherin与β-catenin评估屏障完整性与通透性变化。
研究设计与关键结果
- 研究类型:体外细胞研究;对象为人肺微血管内皮细胞(HLMEC)单层,培养于Transwell小体。
- 干预:ERG CRISPR/cas9敲低质粒、ERG CRISPR激活质粒、重组ERG蛋白或各自对照转染;重组VEGF作为通透性诱导剂。
- CRISPR/cas9敲低ERG及VEGF处理均诱导单层高通透性、VE-cadherin与β-catenin连接处重分布及细胞骨架F-actin应力纤维形成。
- CRISPR激活ERG及重组ERG转染减轻VEGF诱导的单层高通透性;ERG激活保护黏附连接与细胞骨架。
证据类型、等级与局限
- 证据类型:体外细胞研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ERG是人肺微血管内皮细胞屏障完整性与通透性的强效调控因子,内源性或外源性增强ERG可提供对抗屏障功能障碍与高通透性的保护;上述结果来自体外HLMEC单层实验。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
ERG (ETS-related gene) is a member of the ETS (Erythroblast-transformation specific) family of transcription factors abundantly present in vascular endothelial cells. Recent studies demonstrate that ERG has important roles in blood vessel stability and angiogenesis. However, it is unclear how ERG is potentially involved in microvascular barrier functions and permeability. A wide variety of diseases and clinical conditions including trauma-hemorrhagic shock and burn injury are associated with microvascular dysfunctions, which causes excessive microvascular permeability, tissue edema and eventually, multiple organ dysfunction and death. The main purpose of this study was to determine the specific role of ERG in regulating microvascular permeability in human lung microvascular endothelial cells (HLMEC) and to evaluate if exogenous ERG will protect the barrier. The HLMECs were grown on Transwell inserts as monolayers and were transfected with ERG CRISPR/cas9 knockdown plasmid, ERG CRISPR activation plasmid, recombinant ERG protein or their respective controls. Recombinant vascular endothelial growth factor (VEGF) was used as an inducer of permeability for evaluating the effect of ERG activation on permeability. Changes in barrier integrity and permeability were studied using monolayer permeability assay and immunofluorescence of adherens junction proteins (VE-cadherin and β-catenin) respectively. CRISPR/cas9-based ERG knockdown as well as VEGF treatment induced monolayer hyperpermeability, VE-cadherin, and β-catenin junctional relocation and cytoskeletal F-actin stress fiber formation. CRISPR based ERG activation and recombinant ERG transfection attenuated VEGF-induced monolayer hyperpermeability. ERG activation preserved the adherens junctions and cytoskeleton. These results demonstrate that ERG is a potent regulator of barrier integrity and permeability in human lung microvascular endothelial cells and endogenously or exogenously enhancing ERG provides protection against barrier dysfunction and hyperpermeability.
参考来源
- Tharakan B, Hunter FA, Muthusamy S, et al. ETS-Related Gene Activation Preserves Adherens Junctions and Permeability in Microvascular Endothelial Cells. Shock. 2022. PMID: 34907119. doi:10.1097/SHK.0000000000001899
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。